We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: NVIDIA, Netflix, Starbucks, Pfizer, Estee Lauder and Stryker
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 10, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA Corporation (NVDA - Free Report) , Netflix, Inc. (NFLX - Free Report) , Starbucks Corporation (SBUX - Free Report) , Pfizer Inc. (PFE - Free Report) , The Estée Lauder Companies Inc. (EL - Free Report) and Stryker Corporation (SYK - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for NVIDIA, Netflix and Starbucks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA, Netflix and Starbucks. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
NVIDIA shares have outperformed the Zacks General Semiconductor industry in the year-to-date period (+147.6% vs. +36.5%), with the trend expected to continue in the post-pandemic period following the Pfizer vaccine announcement. In fact, any weakness in the stock on the perceived reduced attractiveness of NVIDIA shares given their status as a work-from-home stock should be used as an opportunity to buy into a quality name.
It is also benefiting from strong growth in GeForce desktop and notebook GPUs, which is boosting gaming revenues. Moreover, a surge in Hyperscale demand remains a tailwind for the company’s Data Center business. Expansion of NVIDIA GeForce NOW is expected to drive the user base. Further, solid uptake of AI-based smart cockpit infotainment solutions is a boon.
Additionally, collaboration with Daimler-owned Mercedes-Benz is expected to further strengthen NVIDIA’s presence in the autonomous vehicles and other automotive electronics space. However, management expects COVID-19 pandemic to negatively impact near-term revenues by $100 million. Moreover, the U.S.-China trade war remains a key concern.
Shares of Netflix have gained +75% over the past year against the Zacks Broadcast Radio and Television industry’s rise of +26.2%. The Zacks analyst believes that the company is dominating the streaming space, courtesy of its diversified content portfolio, which is attributable to heavy investments in the production and distribution of localized, foreign-language content and an expanding international footprint.
Netflix, in third-quarter 2020, witnessed decline in paid-user addition rate, reflecting lower demand for content. Additionally, rising competition from Apple, Amazon, HBO Max, Disney+, Peacock and TikTok is a major headwind. Netflix’s leveraged balance sheet and higher streaming obligation is also a concern.
Meanwhile, third-quarter results reflected that Netflix’s low-priced mobile plans in India, Indonesia, Malaysia, Philippines and Thailand is helping it win users in Asia-Pacific, which is a positive for its prospects.
Starbucks shares have gained +19.4% over the past six months against the Zacks Food & Restaurants industry’s rise of +19.9%. The Zacks analyst believes that the company has been benefiting from operating fundamentals such as solid global footprint, successful innovations and digital offerings.
The company anticipates global comparable sales to increase between 18% and 23% in fiscal 2021. Moreover, it anticipates Americas and U.S. comparable store sales to increase in the range of 17% to 22% in fiscal 2021. However, high debt and dismal margin remain concerns.
The company reported fourth-quarter fiscal 2020 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate. However, both the metrics declined sharply year over year. The company had lost nearly $1.2 billion in sales due to the coronavirus pandemic. Although comps declined in the quarter, it improved sequentially in fourth-quarter.
Other noteworthy reports we are featuring today include Estee Lauder Companies and Stryker.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: NVIDIA, Netflix, Starbucks, Pfizer, Estee Lauder and Stryker
For Immediate Release
Chicago, IL – November 10, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA Corporation (NVDA - Free Report) , Netflix, Inc. (NFLX - Free Report) , Starbucks Corporation (SBUX - Free Report) , Pfizer Inc. (PFE - Free Report) , The Estée Lauder Companies Inc. (EL - Free Report) and Stryker Corporation (SYK - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for NVIDIA, Netflix and Starbucks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA, Netflix and Starbucks. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
NVIDIA shares have outperformed the Zacks General Semiconductor industry in the year-to-date period (+147.6% vs. +36.5%), with the trend expected to continue in the post-pandemic period following the Pfizer vaccine announcement. In fact, any weakness in the stock on the perceived reduced attractiveness of NVIDIA shares given their status as a work-from-home stock should be used as an opportunity to buy into a quality name.
It is also benefiting from strong growth in GeForce desktop and notebook GPUs, which is boosting gaming revenues. Moreover, a surge in Hyperscale demand remains a tailwind for the company’s Data Center business. Expansion of NVIDIA GeForce NOW is expected to drive the user base. Further, solid uptake of AI-based smart cockpit infotainment solutions is a boon.
Additionally, collaboration with Daimler-owned Mercedes-Benz is expected to further strengthen NVIDIA’s presence in the autonomous vehicles and other automotive electronics space. However, management expects COVID-19 pandemic to negatively impact near-term revenues by $100 million. Moreover, the U.S.-China trade war remains a key concern.
(You can read the full research report on NVIDIA here >>>)
Shares of Netflix have gained +75% over the past year against the Zacks Broadcast Radio and Television industry’s rise of +26.2%. The Zacks analyst believes that the company is dominating the streaming space, courtesy of its diversified content portfolio, which is attributable to heavy investments in the production and distribution of localized, foreign-language content and an expanding international footprint.
Netflix, in third-quarter 2020, witnessed decline in paid-user addition rate, reflecting lower demand for content. Additionally, rising competition from Apple, Amazon, HBO Max, Disney+, Peacock and TikTok is a major headwind. Netflix’s leveraged balance sheet and higher streaming obligation is also a concern.
Meanwhile, third-quarter results reflected that Netflix’s low-priced mobile plans in India, Indonesia, Malaysia, Philippines and Thailand is helping it win users in Asia-Pacific, which is a positive for its prospects.
(You can read the full research report on Netflix here >>>)
Starbucks shares have gained +19.4% over the past six months against the Zacks Food & Restaurants industry’s rise of +19.9%. The Zacks analyst believes that the company has been benefiting from operating fundamentals such as solid global footprint, successful innovations and digital offerings.
The company anticipates global comparable sales to increase between 18% and 23% in fiscal 2021. Moreover, it anticipates Americas and U.S. comparable store sales to increase in the range of 17% to 22% in fiscal 2021. However, high debt and dismal margin remain concerns.
The company reported fourth-quarter fiscal 2020 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate. However, both the metrics declined sharply year over year. The company had lost nearly $1.2 billion in sales due to the coronavirus pandemic. Although comps declined in the quarter, it improved sequentially in fourth-quarter.
(You can read the full research report on Starbucks here >>>)
Other noteworthy reports we are featuring today include Estee Lauder Companies and Stryker.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.